Results 81 to 90 of about 4,143,408 (248)

Character Builders Review Program

open access: yes, 1931
Character Builders Revue, May 4th & 5th ...
Character Builders
core  

Results from simulations with a single rate of character evolution.

open access: yes, 2014
Bayesian-Mk outperforms parsimony most strongly when the rate of character evolution (and hence homoplasy) is high.
April M. Wright (639415)   +1 more
core   +1 more source

FIGURE 6 in Molecular phylogeny of Onobrychis sect. Onobrychis (Fabaceae-Hedysareae) with insights into its taxonomy and character evolution

open access: yes, 2023
FIGURE 6. Character evolution of chromosome number optimized on the Bayesian tree obtained from nr DNA ITS dataset.Two character states x= 7 vs. x= 8Published as part of Hadadi, Anahita, Kaveh, Akram, Nafisi, Hanyieh & Kazempour-Osaloo, Shahrokh, 2023 ...
Kaveh, Akram   +3 more
core   +1 more source

Classical Complement Pathway Inhibition in a Pediatric Patient With Refractory Immune Thrombocytopenia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric refractory immune thrombocytopenia (rITP) is generally characterized by persistent thrombocytopenia and failure to achieve a sustained response to multiple standard therapies. We report a 4‐year‐old female with congenital tufting enteropathy, post‐intestinal transplant patient on immunosuppressants, who developed severe rITP ...
Sarah Hsieh   +4 more
wiley   +1 more source

Rate Heterogeneity, Ancestral Character State Reconstruction, and the Evolution of Limb Morphology in Lerista (Scincidae, Squamata)

open access: yes, 2010
Rate Heterogeneity, Ancestral Character State Reconstruction, and the Evolution of Limb Morphology in Lerista (Scincidae, Squamata) Alignment and phylogeny from Skinner (2010, Systematic Biology, in press)

core  

Evidence‐Based Clinical Practice Guidelines for the Management of Pediatric Febrile Neutropenia: Resource‐Sensitive Recommendations for the Asian Continent

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Febrile neutropenia (FN) is a frequent and serious complication in children receiving cancer therapy. Standardizing FN management across Asia is challenging due to variable healthcare infrastructure, diagnostic capacity, and infection patterns; however, it could improve resource use and patient outcomes.
Joliza Patricia Cañeba   +29 more
wiley   +1 more source

Evolution, Practice and Enlightenment of the Seascape Character Assessment in the UK

open access: yesHaiyang Kaifa yu guanli, 2022
In order to promote the scientific management of seascape and the construction of beautiful cities in China, this paper reviewed the evolution of seascape character assessment in the UK, in particular discussed assessment practice and implications of ...
Fang QIAN, Rui ZHANG, Siqi CHEN
doaj  

Phylogeny of the non-monophyletic Cayratia Juss. (Vitaceae) and implications for character evolution and biogeography

open access: yes, 2013
Cayratia consists of ca. 60 species primarily distributed in the tropical and subtropical regions of Asia, Australia, and Africa. It is an excellent candidate for exploring the evolution of intercontinental disjunct distributions in the Old World ...
Zhiduan Chen   +7 more
core   +1 more source

Abatacept for Prophylaxis of Acute and Chronic Graft‐Versus‐Host‐Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation—A Systematic Review and Meta‐Analysis of Cohort Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Graft‐versus‐host disease (GvHD) remains one of the most significant complications of hematopoietic stem cell transplantation (HSCT). Abatacept, a selective T‐cell costimulation modulator, is a relatively novel prophylactic agent, though pediatric data remain limited.
Matthijs D. Kruizinga   +3 more
wiley   +1 more source

Bounding probabilities in a Markovian model of character evolution [PDF]

open access: yes, 1995
We investigate a probability-based model of character evolution. Using Erdos-Szekely path systems, a sharp upper bound for the probability of a given character evolving under this model is obtained in terms of its parsimony length.
Tuffley, Christopher
core   +1 more source

Home - About - Disclaimer - Privacy